• Cogstate Ltd achieved record sales, revenue, and profit in FY26.
• The company delivered $60.9m in revenue, with a 25% EBIT margin.
• Cogstate secured $89.0m in contracted revenue for FY27, a 116% increase.
• The company expects FY27 revenue of $48.3m, up 54% year-over-year.
• Cogstate plans to invest in AI and automation to enhance scalability and margins.

Cogstate Ltd, a neuroscience technology company, released its FY26 results, highlighting record sales, revenue, and profit. The company reported $60.9m in revenue, a 15% increase from the previous year, and a 25% EBIT margin. Cogstate secured $89.0m in contracted revenue for FY27, up 116% year-over-year, with $48.3m expected to be recognized in FY27. The company also announced an increased annual dividend and a share buyback program. Cogstate plans to invest in AI and automation to enhance scalability and margins, with a focus on expanding into new indications and strengthening its global footprint through strategic partnerships.

FY27 expected revenue: $48.3m, up 54% year-over-year

Cogstate expects a second-half bias in FY27 financial results, with continued investment in technology and AI-enabled workflows. The company aims to maintain FY26 annual EBITDA margins despite increased investments.